The HIPAA Singularity: Reconciling Artificial Intelligence, Cybersecurity, and Patient Rights in the U.S. Healthcare Legal Framework


International Research Journal of Economics and Management Studies
© 2025 by IRJEMS
Volume 4  Issue 9
Year of Publication : 2025
Authors : Abdullah Mazharuddin Khaja, Aftab Tariq, Michidmaa Arikhad, Tamoor Ali Sadiq
irjems doi : 10.56472/25835238/IRJEMS-V4I9P105

Citation:

Abdullah Mazharuddin Khaja, Aftab Tariq, Michidmaa Arikhad, Tamoor Ali Sadiq. "The HIPAA Singularity: Reconciling Artificial Intelligence, Cybersecurity, and Patient Rights in the U.S. Healthcare Legal Framework" International Research Journal of Economics and Management Studies, Vol. 4, No. 9, pp. 46-54, 2025. Crossref. http://doi.org/10.56472/25835238/IRJEMS-V4I9P105

Abstract:

The integration of artificial intelligence (AI) into the U.S. healthcare system promises transformative benefits, including enhanced diagnostics, improved operational efficiency, and more personalized treatments. However, these advances amplify persistent concerns surrounding patient privacy, cybersecurity vulnerabilities, and autonomy. The Health Insurance Portability and Accountability Act of 1996 (HIPAA) remains the primary statutory safeguard for medical information; however, its definitions and implementation frameworks were designed for a pre-AI, pre-cloud computing environment. This paper investigates how HIPAA can adapt to address the intersecting challenges of AI-driven medical innovation and escalating cybersecurity threats while upholding patient rights. Drawing on interdisciplinary legal, technical, and ethical literature, as well as empirical breach data, we highlight systemic gaps. Analysis of federal reporting reveals that hacking incidents accounted for nearly 80% of healthcare data breaches in 2023, with exposed records escalating from 41 million in 2019 to more than 276 million in 2024. Additionally, a 2025 survey of U.S. health systems demonstrated universal adoption of generative AI for clinical documentation, contrasted with lower performance in imaging and sepsis detection. These findings underscore an urgent need for regulatory modernization. We argue that HIPAA must evolve to include AI-specific provisions, mandate robust cybersecurity controls, and strengthen patient consent mechanisms. Proposed reforms include statutory amendments introducing algorithmic accountability, mandatory encryption standards, transparent de-identification practices, and oversight mechanisms designed to balance innovation with equity. Without proactive legal reform, the convergence of AI deployment and cyber vulnerabilities risks eroding public trust and hindering the ethical and sustainable integration of AI in healthcare.

References:

[1] H. Rafi, H. Rafiq, and M. Farhan, “Agmatine alleviates brain oxidative stress induced by sodium azide,” 2023.
[2] S. I. Haider and M. Ali, “Mitigating the challenges of open and distance learning education system through use of information technology: a case study of Allama Iqbal Open University, Islamabad, Pakistan,” Pakistan Journal of Distance and Online Learning, vol. 5, no. 2, pp. 175–190, 2019.
[3] A. Raza, “AI and privacy – navigating a world of constant surveillance,” Euro Vantage Journal of Artificial Intelligence, vol. 1, no. 2, pp. 74–80, 2024.
[4] S. Khan, S. Mehmood, and S. I. Haider, “Child abuse in automobile workshops in Islamabad, Pakistan,” Pakistan Journal of Criminology, vol. 12, no. 1, pp. 61–74, 2020.
[5] T. Ghulam, H. Rafi, A. Khan, K. Gul, and M. Z. Yusuf, “Impact of SARS-CoV-2 treatment on development of sensorineural hearing loss,” Proceedings of the Pakistan Academy of Sciences: B. Life and Environmental Sciences, vol. 58, suppl., pp. 45–54, 2021.
[6] D. K. Mizouri et al., “Use of large language model chatbots in health care: privacy, cybersecurity, and ethical risks,” Journal of Medical Internet Research, vol. 25, p. e47617, 2023.
[7] H. Rafiq, M. Farhan, H. Rafi, S. Rehman, M. Arshad, and S. Shakeel, “Inhibition of drug-induced Parkinsonism by chronic supplementation of quercetin in haloperidol-treated Wistars,” Pakistan Journal of Pharmaceutical Sciences, vol. 35, pp. 1655–1662, 2022.
[8] A. Raza, “Trade secrets as a substitute for AI protection: a critical investigation into different dimensions of trade secrets,” 2024.
[9] G. Palmeri, “Divine disguises on the crossroads of Khotan: The iconographies from Dandan Oilik,” Journal of Asian Civilizations, vol. 44, no. 2, pp. 67–107, 2021.
[10] A. Ali, S. I. Haider, and M. Ali, “Role of identities in the Indo-Pak relations: a study in constructivism,” Global Regional Review, vol. 2, no. 1, pp. 305–319, 2017.
[11] A. Raza, “Equality before law and equal protection of law: contextualising its evolution in Pakistan,” Pakistan Law Journal, 2023.
[12] L. Notebaert, R. Harris, C. MacLeod, M. Crane, and R. S. Bucks, “The role of acute stress recovery in emotional resilience,” PeerJ, vol. 12, p. e17911, 2024.
[13] A. Raza and N. Bashir, “Artificial intelligence as a creator and inventor: legal challenges and protections in copyright, patent, and trademark law,” Dec. 2023.
[14] M. Farhan, H. Rafi, and H. Rafiq, “Dapoxetine treatment leads to attenuation of chronic unpredictable stress-induced behavioral deficits in a rat model of depression,” Journal of Pharmacy and Nutrition Sciences, vol. 5, no. 4, pp. 222–228, 2015.
[15] Z. Ahmed, S. Khan, S. Saeed, and S. I. Haider, “An overview of educational policies of Pakistan (1947–2020),” Psychology and Education Journal, vol. 58, no. 1, pp. 4459–4463, 2021.
[16] A. Raza, “Credit, code, and consequence: how AI is reshaping risk assessment and financial equity,” Euro Vantage Journal of Artificial Intelligence, vol. 2, no. 2, pp. 79–86, 2025.
[17] S. I. Haider and F. M. Burfat, “Improving self-esteem, assertiveness and communication skills of adolescents through life skills-based education,” Journal of Social Sciences and Humanities (JSSH), vol. 26, no. 2, 2018.
[18] H. Rafi and M. Farhan, “Dapoxetine: an innovative approach in therapeutic management in animal model of depression,” Pakistan Journal of Pharmaceutical Sciences, vol. 2, no. 1, pp. 15–22, 2015.
[19] S. Zuberi, H. Rafi, A. Hussain, and S. Hashmi, “Upregulation of Nrf2 in myocardial infarction and ischemia-reperfusion injury of the heart,” PLOS One, vol. 19, no. 3, p. e0299503, 2024.
[20] A. Raza, B. Munir, G. Ali, M. A. Othi, and R. A. Hussain, “Balancing privacy and technological advancement in AI: a comprehensive analysis of the US perspective,” International Journal of Contemporary Issues in Social Sciences, vol. 3, no. 3, pp. 3732–3738, 2024.
[21] S. I. Haider and A. Waqar, “Projection of CPEC in print media of Pakistan from 2014–2019,” Global Strategic and Security Studies Review, vol. 1, pp. 45–64, 2019.
[22] H. Rafi, H. Rafiq, R. Khan, F. Ahmad, J. Anis, and M. Farhan, “Neuroethological study of AlCl₃ and chronic forced swim stress induced memory and cognitive deficits in albino rats,” The Journal of Neurobehavioral Sciences, vol. 6, no. 2, pp. 149–158, 2019.
[23] I. Bhatti, H. Rafi, and S. Rasool, “Use of ICT technologies for the assistance of disabled migrants in the USA,” Revista Española de Documentación Científica, vol. 18, no. 1, pp. 66–99, 2024.
[24] F. Rasool and S. I. Haider, “Exploitation and low wages of labor migrants in Gulf countries,” Global Management Sciences Review, vol. 1, pp. 32–39, 2020.
[25] M. Farhan, H. Rafiq, H. Rafi, S. Rehman, and M. Arshad, “Quercetin impact against psychological disturbances induced by fat-rich diet,” Pakistan Journal of Pharmaceutical Sciences, vol. 35, no. 5, 2022.
[26] U.S. Department of Health and Human Services, “Administrative simplification: proposed modifications to the HIPAA Security Rule to strengthen cybersecurity,” Dec. 2024. [Online]. Available: https://www.hhs.gov.
[27] H. Rafi, H. Rafiq, I. Hanif, R. Rizwan, and M. Farhan, “Chronic agmatine treatment modulates behavioral deficits induced by chronic unpredictable stress in Wistar rats,” Journal of Pharmaceutical and Biological Sciences, vol. 6, no. 3, pp. 80–85, 2018.
[28] Z. Zafar, I. Sarwar, and S. I. Haider, “Socio-economic and political causes of child labor: the case of Pakistan,” Global Political Review, vol. 1, no. 1, pp. 32–43, 2016.
[29] A. Raza, “Navigating the intersection of artificial intelligence and law in healthcare: complications and corrections,” 2024.
[30] M. Farhan, H. Rafi, and H. Rafiq, “Behavioral evidence of neuropsychopharmacological effect of imipramine in an animal model of unpredictable stress-induced depression,” International Journal of Biology and Biotechnology, vol. 15, no. 22, pp. 213–221, 2018.
[31] A. Raza, “Trade secrets as a substitute for AI protection: a critical investigation into different dimensions of trade secrets,” 2024.
[32] J. N. Allen, “AI chatbots and HIPAA compliance: responsibilities for developers and health providers,” Harvard Law Review Blog, 2023.
[33] M. F. Muhammad, H. Rafiq, and H. Rafi, “Prevalence of depression in an animal model of high-fat diet-induced obesity,” 2015.
[34] H. Rafi, H. Rafiq, and M. Farhan, “Pharmacological profile of agmatine: an in-depth overview,” Neuropeptides, vol. 105, p. 102429, 2024.
[35] S. I. Haider and N. K. Mahsud, “Family, peer group and adaptation of delinquent behavior,” Dialogue (Pakistan), vol. 5, no. 4, 2010.
[36] H. Rafi, F. Ahmad, J. Anis, R. Khan, H. Rafiq, and M. Farhan, “Comparative effectiveness of agmatine and choline treatment in rats with cognitive impairment induced by AlCl₃ and forced swim stress,” Current Clinical Pharmacology, vol. 15, no. 3, pp. 251–264, 2020.
[37] A. Raza, “Credit, code, and consequence: how AI is reshaping risk assessment and financial equity,” Euro Vantage Journal of Artificial Intelligence, vol. 2, no. 2, pp. 79–86, 2025.
[38] D. D. Farhud and S. Zokaie, “Ethical issues of artificial intelligence in medicine and health care,” Iranian Journal of Public Health, vol. 50, no. 11, pp. i–vi, 2021.
[39] M. Zubair, S. I. Haider, and F. Khattak, “The implementation challenges to women protection laws in Pakistan,” Global Regional Review, vol. 3, no. 1, pp. 253–264, 2018.
[40] H. Rafiq, M. Farhan, H. Rafi, S. Rehman, and M. Arshad, “Quercetin impact against psychological disturbances induced by fat-rich diet,” Pakistan Journal of Pharmaceutical Sciences, vol. 35, no. 5, 2022.
[41] S. Khan, S. I. Haider, and R. Bakhsh, “Socio-economic and cultural determinants of maternal and neonatal mortality in Pakistan,” Global Regional Review, vol. 1, pp. 1–7, 2020.
[42] H. Rafi, H. Rafiq, and M. Farhan, “Antagonisation of monoamine reuptake transporters by agmatine improves anxiolytic and locomotive behaviors commensurate with fluoxetine and methylphenidate,” Beni-Suef University Journal of Basic and Applied Sciences, vol. 10, no. 1, p. 26, 2021.
[43] A. Raza, “The application of artificial intelligence in credit risk evaluation: obstacles and opportunities in the path to financial justice,” Center for Management Science Research, vol. 3, no. 2, pp. 240–251, 2025.
[44] L. Gordon, M. Loeb, and W. Lucyshyn, “The economics of information security investment,” Information Systems Frontiers, vol. 17, no. 1, pp. 51–70, 2015.
[45] H. Rafi, H. Rafiq, and M. Farhan, “Inhibition of NMDA receptors by agmatine is followed by GABA/glutamate balance in benzodiazepine withdrawal syndrome,” Beni-Suef University Journal of Basic and Applied Sciences, vol. 10, no. 1, p. 43, 2021.
[46] A. Raza and N. Bashir, “Artificial intelligence as a creator and inventor: legal challenges and protections in copyright, patent, and trademark law,” Dec. 2023.
[47] I. H. Syed, W. A. Awan, and U. B. Syeda, “Caregiver burden among parents of hearing impaired and intellectually disabled children in Pakistan,” Iranian Journal of Public Health, vol. 49, no. 2, pp. 249–256, Feb. 2020.
[48] A. Raza, “Equality before law and equal protection of law: contextualising its evolution in Pakistan,” Pakistan Law Journal, 2023.
[49] S. Zuberi, H. Rafi, A. Hussain, and S. Hashmi, “Role of Nrf2 in myocardial infarction and ischemia-reperfusion injury,” Physiology, vol. 38, suppl. 1, p. 5734743, 2023.
[50] M. Farhan, H. Rafiq, H. Rafi, F. Siddiqui, R. Khan, and J. Anis, “Study of mental illness in rat model of sodium azide induced oxidative stress,” Journal of Pharmacy and Nutrition Sciences, vol. 9, no. 4, pp. 213–221, 2019.
[51] A. Raza, B. Munir, G. Ali, M. A. Othi, and R. A. Hussain, “Balancing privacy and technological advancement in AI: a comprehensive analysis of the US perspective,” International Journal of Contemporary Issues in Social Sciences, vol. 3, no. 3, pp. 3732–3738, 2024.
[52] S. I. Haider, B. A. Shah, and N. Jehan, “Socio-economic impact of emigration on the family members left behind: A case study of district Rawalpindi,” Global Regional Review, vol. 2, no. 1, pp. 241–252, 2017.
[53] H. Rafi, H. Rafiq, and M. Farhan, “Agmatine improves oxidative stress profiles in rat brain tissues induced by sodium azide,” Current Chemical Biology, vol. 18, no. 3, pp. 129–143, 2024.
[54] S. I. Haider and N. K. Mashud, “Knowledge, attitude, and practices of violence: A study of university students in Pakistan,” Journal of Sociology and Social Work, vol. 2, no. 1, pp. 123–145, 2014.
[55] A. M. Desai et al., “Generative AI in health systems: adoption and challenges,” Journal of the American Medical Informatics Association, vol. 31, no. 2, pp. 133–150, 2025.
[56] H. Rafi, H. Rafiq, R. Khan, F. Ahmad, J. Anis, and M. Farhan, “Neuroethological study of AlCl₃ and chronic forced swim stress induced memory and cognitive deficits in albino rats,” The Journal of Neurobehavioral Sciences, vol. 6, no. 2, pp. 149–158, 2019.
[57] D. J. Cullen and D. J. Nicholson, “Artificial intelligence and privacy in health care,” in Research Handbook on Health, AI and the Law, 1st ed., Cheltenham: Edward Elgar, 2023, ch. 8.
[58] M. Farhan, H. Rafiq, and H. Rafi, “Prevalence of depression in animal model of high-fat diet induced obesity,” Journal of Pharmacy and Nutrition Sciences, vol. 5, no. 3, pp. 208–215, 2015.
[59] F. Shafqat, S. I. Haider, A. R. Rao, and S. Waqar, “Depression, anxiety, and stress in rural and urban population of Islamabad,” The Rehabilitation Journal, vol. 2, no. 1, pp. 44–48, 2018.
[60] M. Zubair, S. I. Haider, and F. Khattak, “The Implementation Challenges to Women Protection Laws in Pakistan,” Global Regional Review, vol. 3, no. 1, pp. 253–264, 2018.
[61] A. Raza, “Credit, code, and consequence: how AI is reshaping risk assessment and financial equity,” Euro Vantage Journal of Artificial Intelligence, vol. 2, no. 2, pp. 79–86, 2025.
[62] S. I. Haider and A. Waqar, “Projection of CPEC in print media of Pakistan from 2014–2019,” Global Strategic and Security Studies Review, vol. 1, pp. 45–64, 2019.
[63] H. Rafi, H. Rafiq, and M. Farhan, “Pharmacological profile of agmatine: an in-depth overview,” Neuropeptides, vol. 105, p. 102429, 2024.
[64] M. Farhan, H. Rafi, and H. Rafiq, “Dapoxetine treatment leads to attenuation of chronic unpredictable stress-induced behavioral deficits in a rat model of depression,” Journal of Pharmacy and Nutrition Sciences, vol. 5, no. 4, pp. 222–228, 2015.
[65] L. Notebaert, R. Harris, C. MacLeod, M. Crane, and R. S. Bucks, “The role of acute stress recovery in emotional resilience,” PeerJ, vol. 12, p. e17911, 2024.
[66] M. Farhan, H. Rafiq, H. Rafi, R. Ali, and S. Jahan, “Neuroprotective role of quercetin against neurotoxicity induced by lead acetate in male rats,” unpublished.
[67] S. Khan and S. I. Haider, “Women’s education and empowerment in Islamabad, Pakistan,” Global Economics Review, vol. 5, no. 1, pp. 50–62, 2020.
[68] A. Raza, “AI and privacy – navigating a world of constant surveillance,” Euro Vantage Journal of Artificial Intelligence, vol. 1, no. 2, pp. 74–80, 2024.
[69] D. D. Farhud and S. Zokaie, “Ethical issues of artificial intelligence in medicine and health care,” Iranian Journal of Public Health, vol. 50, no. 11, pp. i–vi, 2021.
[70] S. I. Haider and N. K. Mahsud, “Family, Peer Group and Adaptation of Delinquent Behavior,” Dialogue (Pakistan), vol. 5, no. 4, 2010.
[71] A. Raza and N. Bashir, “Artificial intelligence as a creator and inventor: legal challenges and protections in copyright, patent, and trademark law,” Dec. 2023.
[72] Z. Ahmed, S. Khan, S. Saeed, and S. I. Haider, “An overview of educational policies of Pakistan (1947–2020),” Psychology and Education Journal, vol. 58, no. 1, pp. 4459–4463, 2021.
[73] A. Ali, S. I. Haider, and M. Ali, “Role of identities in the Indo-Pak relations: a study in constructivism,” Global Regional Review, vol. 2, no. 1, pp. 305–319, 2017.
[74] A. Raza, “Navigating the intersection of artificial intelligence and law in healthcare: complications and corrections,” 2024.
[75] D. K. Mizouri et al., “Use of large language model chatbots in health care: privacy, cybersecurity, and ethical risks,” Journal of Medical Internet Research, vol. 25, p. e47617, 2023.
[76] H. Rafi, F. Ahmad, J. Anis, R. Khan, H. Rafiq, and M. Farhan, “Comparative effectiveness of agmatine and choline treatment in rats with cognitive impairment induced by AlCl₃ and forced swim stress,” Current Clinical Pharmacology, vol. 15, no. 3, pp. 251–264, 2020.
[77] J. N. Allen, “AI chatbots and HIPAA compliance: responsibilities for developers and health providers,” Harvard Law Review Blog, 2023.
[78] M. Farhan, H. Rafiq, and H. Rafi, “Behavioral evidence of neuropsychopharmacological effect of imipramine in an animal model of unpredictable stress-induced depression,” International Journal of Biology and Biotechnology, vol. 15, no. 22, pp. 213–221, 2018.
[79] S. Khan, S. Mehmood, and S. I. Haider, “Child abuse in automobile workshops in Islamabad, Pakistan,” Pakistan Journal of Criminology, vol. 12, no. 1, pp. 61–74, 2020.
[80] A. M. Desai et al., “Generative AI in health systems: adoption and challenges,” Journal of the American Medical Informatics Association, vol. 31, no. 2, pp. 133–150, 2025.

Keywords:

Marketing Mix, Customer Satisfaction, Wondr by BNI.